Nicotine Prototype Mini lozenge

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Tobacco Use Disorder

Phase 1

A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers

CompletedNCT03541044

GlaxoSmithKlineTobacco Use Disorder

Start: 2018-06-18End: 2019-03-24Updated: 2020-03-12

To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

CompletedNCT03543137

GlaxoSmithKlineTobacco Use Disorder

Start: 2018-06-18End: 2018-11-12Updated: 2019-12-04